Cargando…

Comparing Invasive Pulmonary Aspergillosis Mortality Between Liposomal Amphotericin B and Voriconazole in Patients With Hematological Malignancy or Hematopoietic Stem Cell Transplantation

Objectives We evaluated liposomal amphotericin B versus voriconazole for the treatment of invasive pulmonary aspergillosis (IPA) in patients with hematological malignancy or hematopoietic stem cell transplantation (HSCT). Methods This retrospective cohort, single-center study included patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmoud, Ebrahim, Alzahrani, Mohsen, Loutfi, Shukri, Alqahatani, Hajar Y, Bosaeed, Mohammad, Ahmed, Ayoub, Alahmari, Bader, Alsadi, Husam, Ahmed, Mazin, Al Dhoayan, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771842/ https://www.ncbi.nlm.nih.gov/pubmed/36569688 http://dx.doi.org/10.7759/cureus.31762

Ejemplares similares

Amphotericin-B-liposomal/voriconazole: Renal impairment: case report
Publicado: (2021)

Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis
por: Hamada, Noboru, et al.
Publicado: (2021)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
por: Efe İris, Nur, et al.
Publicado: (2016)

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain
por: Ostermann, Helmut, et al.
Publicado: (2014)

Amphotericin-B-liposomal/isavuconazole/voriconazole: Lack of efficacy: 6 case report
Publicado: (2022)

1639. Efficacy of Voriconazole Prophylaxis Followed by Therapeutic Liposomal Amphotericin B for the Treatment of Murine Pulmonary Aspergillosis Caused by Azole-Resistant Aspergillus fumigatus Strains
por: Olson, Jon, et al.
Publicado: (2018)

Amphotericin-B liposomal/voriconazole: Drug induced liver injury and hypokalaemia: case report
Publicado: (2021)

Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update
por: Duckwall, Madison J, et al.
Publicado: (2019)

2105. Liposomal Amphotericin B Use Before and After Implementation of Voriconazole Prophylaxis in Cancer Patients
por: Shams, Madeeha, et al.
Publicado: (2019)

Amphotericin-B-liposomal/prednisone/voriconazole: Photosensitivity, cicatricial ectropion and lack of efficacy: case report
Publicado: (2022)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
por: Turner, Stuart J, et al.
Publicado: (2013)

Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis
por: Chai, Louis Yi Ann, et al.
Publicado: (2014)

Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice
por: Rousseau, Nathalie, et al.
Publicado: (2014)

Efficacy of voriconazole and amphotericin B in corneal preservative media
por: Das, Sujata, et al.
Publicado: (2022)

Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
por: Serraj, Khalid, et al.
Publicado: (2020)

Orbital Aspergillosis: Voriconazole – The New Standard Treatment?
por: Ohlstein, Derek H., et al.
Publicado: (2012)

1577. Particle Characterization of Nebulized Liposomal Amphotericin B and Its Use in the Treatment of Murine Pulmonary Aspergillosis
por: Dave, Janam J, et al.
Publicado: (2019)

Trichosporon faecale invasive infection in a patient with severe aplastic anemia: Efficacy of voriconazole and liposomal amphotericin B before neutrophil recovery
por: Pérard, Baptiste, et al.
Publicado: (2015)

Developing Machine-Learning Prediction Algorithm for Bacteremia in Admitted Patients
por: Mahmoud, Ebrahim, et al.
Publicado: (2021)

Liposomal amphotericin B—the present
por: Maertens, J, et al.
Publicado: (2022)

Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022)

Liposomal amphotericin B—the future
por: Hoenigl, M, et al.
Publicado: (2022)

High weekly doses of liposomal amphotericin B as secondary prophylaxis after cerebral aspergillosis in a paediatric patient()
por: Brazzola, Pierluigi, et al.
Publicado: (2013)

Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
por: Van Ackerbroeck, Sofie, et al.
Publicado: (2021)

Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis
por: Feys, Simon, et al.
Publicado: (2023)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
por: Sarfati, Sacha, et al.
Publicado: (2022)

When Azoles Cannot Be Used: The Clinical Effectiveness of Intermittent Liposomal Amphotericin Prophylaxis in Hematology Patients
por: Batchelor, R, et al.
Publicado: (2021)

Treatment of a Locally Invasive Cutaneous Fusarium Species Infection With Voriconazole and Liposomal Amphotericin B in a Patient With Relapsed Acute Myeloid Leukemia
por: Meyer, Sara Anne, et al.
Publicado: (2017)

Refractory Scedosporium apiospermum Keratitis Successfully Treated with Combination of Amphotericin B and Voriconazole
por: Fadzillah, Mohd-Tahir, et al.
Publicado: (2013)

Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
por: Akers, Kevin S, et al.
Publicado: (2015)

Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole
por: Mithal, Kopal, et al.
Publicado: (2015)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

Management of invasive aspergillosis in patients with COPD: Rational use of voriconazole
por: Ader, Florence, et al.
Publicado: (2009)

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial
por: Cadranel, J., et al.
Publicado: (2012)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Outcome of Middle East Respiratory Syndrome (MERS) in hematology and oncology patients: A case series in Saudi Arabia
por: Alaskar, Ahmed, et al.
Publicado: (2021)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

Middle East Respiratory Syndrome (MERS) Infection in Hematological and Oncological Patients: A Case Series from a Tertiary Care Center in Saudi Arabia
por: Alaskar, Ahmed, et al.
Publicado: (2019)

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature
por: Sandherr, M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_iqhkt24g8gfuv5qe5ch52tarra